Cargando…
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
Ejemplares similares
-
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)
por: Giardino, Giuliana, et al.
Publicado: (2022) -
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers
por: Cinetto, Francesco, et al.
Publicado: (2021) -
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022
por: Milito, Cinzia, et al.
Publicado: (2023) -
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic
por: Garzi, Giulia, et al.
Publicado: (2022) -
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
por: Milito, Cinzia, et al.
Publicado: (2022)